Contineum Therapeutics, Inc. Class A Common Stock (CTNM) - Insider Trading | Relativity Invest

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) - Insider Trading | Relativity Invest

Company Summary Stats

H.BearBearishNeutralBullishH.Bull

27.7

Insider Trading Score

Peer Group Scores

Recent Insider Trades

Filing Date	Insider	Type	10b5-1	Net Shares	Ownership change	Avg. Price	Value	Filing
2026-06-01	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.91%139,372	$13.16	$54,862	View SEC filing
2026-05-01	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.82%143,542	$13.12	$54,694	View SEC filing
2026-04-06	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.75%147,712	$13.43	$56,014	View SEC filing
2026-03-02	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.67%151,882	$15.01	$62,585	View SEC filing
2026-03-02	Watkins Tim CMO & Head of Development	Sale		-3,611	-100.00%0	$15.02	$54,220	View SEC filing
2026-02-26	Stengone Carmine N. CEO and President	Sale		-7,100	-22.73%14,954	$16.02	$113,728	View SEC filing
2026-02-26	Lorrain Daniel S. Chief Scientific Officer	Sale		-8,124	-2.68%156,052	$16.02	$130,164	View SEC filing
2026-02-20	Lorrain Daniel S. Chief Scientific Officer	Sale		-100	-0.06%156,052	$16.00	$1,600	View SEC filing
2026-02-13	Stengone Carmine N. CEO and President	Sale		-400	-2.61%14,954	$16.00	$6,400	View SEC filing
2026-02-13	Lorrain Daniel S. Chief Scientific Officer	Sale		-400	-0.26%156,052	$16.00	$6,400	View SEC filing
2026-02-05	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.60%156,052	$14.94	$62,305	View SEC filing
2026-01-30	Watkins Tim CMO & Head of Development	Sale		-3,611	-100.00%0	$14.18	$51,188	View SEC filing
2026-01-06	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.54%160,222	$10.44	$43,543	View SEC filing
2025-12-30	Watkins Tim CMO & Head of Development	Sale		-3,611	-100.00%0	$12.06	$43,558	View SEC filing
2025-12-30	Lorrain Daniel S. Chief Scientific Officer	Sale		-4,170	-2.47%164,392	$12.23	$51,009	View SEC filing
2024-11-27	Lorrain Daniel S. Chief Scientific Officer	Sale		-1,010	-0.60%168,562	$16.02	$16,177	View SEC filing
2024-11-20	Lorrain Daniel S. Chief Scientific Officer	Sale		-6,190	-3.52%169,572	$16.38	$101,421	View SEC filing

1-17 of 17

Page 1 of 1